Tae-Sung Koo

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Pluripotent Stem Cells

Venous Thromboembolism

Liquid Chromatography Tandem Mass Spectrometry

Quality Control

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Hae-In Choi, Taeheon Kim, Jin-Woo Kim, Gi Ju Lee, Jinyoung Choi, Yoon-Jee Chae, Eunhee Kim, Tae-Sung Koo
Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson's Disease Candidate, Using LC-MS/MS and LC-HRMS. Molecules (Basel, Switzerland) 29 (5) (2024)
Hae-In Choi, Taeheon Kim, Jin-Woo Kim, Gi Ju Lee, Jinyoung Choi, Yoon-Jee Chae, Eunhee Kim, Tae-Sung Koo
Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson's Disease Candidate, Using LC-MS/MS and LC-HRMS. Molecules (Basel, Switzerland) 29 (5) (2024)
Hae-In Choi, Jinyoung Choi, Jin-Woo Kim, Yoon Ha Lee, Kwan Hyung Cho, Tae-Sung Koo
Stability Evaluation and Pharmacokinetic Profiling of Vepdegestrant in Rodents Using Liquid Chromatography-Tandem Mass Spectrometry. Molecules (Basel, Switzerland) 29 (17) (2024)
Hae-In Choi, Taeheon Kim, Jin-Woo Kim, Gi Ju Lee, Jinyoung Choi, Yoon-Jee Chae, Eunhee Kim, Tae-Sung Koo
Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson's Disease Candidate, Using LC-MS/MS and LC-HRMS. Molecules (Basel, Switzerland) 29 (5) (2024)
Dong-Jin Jang, Jun Hak Lee, Da Hun Kim, Jin-Woo Kim, Tae-Sung Koo, Kwan Hyung Cho
The Development of Super-Saturated Rebamipide Eye Drops for Enhanced Solubility, Stability, Patient Compliance, and Bioavailability. Pharmaceutics 15 (3) (2023)
Dong-Jin Jang, Jun Hak Lee, Da Hun Kim, Jin-Woo Kim, Tae-Sung Koo, Kwan Hyung Cho
The Development of Super-Saturated Rebamipide Eye Drops for Enhanced Solubility, Stability, Patient Compliance, and Bioavailability. Pharmaceutics 15 (3) (2023)
Dong-Jin Jang, Jun Hak Lee, Da Hun Kim, Jin-Woo Kim, Tae-Sung Koo, Kwan Hyung Cho
The Development of Super-Saturated Rebamipide Eye Drops for Enhanced Solubility, Stability, Patient Compliance, and Bioavailability. Pharmaceutics 15 (3) (2023)
Thi-Thao-Linh Nguyen, Jin-Woo Kim, Hae-In Choi, Han-Joo Maeng, Tae-Sung Koo
Development of an LC-MS/MS Method for ARV-110, a PROTAC Molecule, and Applications to Pharmacokinetic Studies. Molecules (Basel, Switzerland) 27 (6) (2022)
Eun-Sil Lee, Nayeon Kim, Joon Hee Kang, Aizhan Abdildinova, Seon-Hyeong Lee, Myung Hwi Lee, Nam Sook Kang, Tae-Sung Koo, Soo-Youl Kim, Young-Dae Gong
Design and Synthesis of a Novel 4-aryl-N-(2-alkoxythieno [2,3- b ]pyrazine-3-yl)-4-arylpiperazine-1-carboxamide DGG200064 Showed Therapeutic Effect on Colon Cancer through G2/M Arrest. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Jong-Hwa Lee, Hyeong Sik Jeong, Jong-Woo Jeong, Tae-Sung Koo, Do-Kyun Kim, Young Ho Cho, Gye Won Lee
The Development and Optimization of Hot-Melt Extruded Amorphous Solid Dispersions Containing Rivaroxaban in Combination with Polymers. Pharmaceutics 13 (3) (2021)
Yoo-Kyung Song, Yun-Hwan Seol, Min Ju Kim, Jong-Woo Jeong, Hae-In Choi, Seung-Won Lee, Yoon-Jee Chae, Sunjoo Ahn, Young-Dae Gong, Kyeong-Ryoon Lee, Tae-Sung Koo
Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats. Pharmaceutics 13 (3) (2021)